Sedy Line is a high-capacity lipolytic solution from Maypharm, sold in a 60 ml format and positioned for both face and body fat. Its main ingredients are sodium deoxycholate, L-carnitine, vitamin B12, and botanical extracts. This is a medical procedure for a licensed professional, never a DIY shortcut.

What is Sedy Line, and what is in it?

Sedy Line is a fat-dissolving injectable made by the Korean maker Maypharm. Its main active is sodium deoxycholate, the salt form of deoxycholic acid, a bile acid the body uses to emulsify dietary fat. The blend also includes L-carnitine, which helps the body process fatty acids, vitamin B12, and botanical extracts such as Centella asiatica and walnut seed.

The number that stands out is the 60 ml format, a large volume that signals body positioning alongside facial use. The manufacturer describes the mechanism with the term “adipocytolysis,” meaning the destruction of fat-cell membranes for what it calls an irreversible reduction. Treat that wording as the maker’s claim, not a guaranteed or proven outcome.

Log Notes. This page explains what Sedy Line is and the mechanism its maker describes. It gives no doses, volumes, injection sites, depths, session counts, or technique. Those belong to a licensed professional and the official guide, not a blog. Nothing here is medical advice, and injectable lipolysis is never a do-it-yourself procedure.

Is Sedy Line FDA-approved, and what are the risks?

This is the honest core of the post, and the large body-capable format makes it especially important. Deoxycholic acid is the only fat-dissolving ingredient with FDA approval, sold as Kybella, and only for fat under the chin (submental fat), not the body. So high-volume body use of a deoxycholate product like Sedy Line is off-label, and Korean lipolytics like this are generally not FDA-approved at all.

The FDA is direct about the broader category. It warns that fat-dissolving injections that are not FDA-approved can be harmful and that it cannot confirm their safety, quality, or effectiveness. Larger volumes over wider areas raise the stakes, not lower them. Injectable lipolysis carries real risks, swelling, bruising, nodules, nerve injury, and uneven results among them, so this remains a medical decision for a qualified professional.

What should you expect, and what is worth tracking?

Slow change and a thorough record. Lipolysis is discussed as a course, and any reduction in a treated area appears gradually over weeks, especially across the larger zones a 60 ml product targets. That timeline makes a dated log far more useful than memory and far more honest than a single photo.

This is where Dosefi fits a careful routine. If you pursue Sedy Line with a licensed professional, you log each session with its date and a photo, set a reminder for the review window your provider gives you, and self-rate each treated area so trends build over the weeks that follow. A log never makes a procedure safe; it simply keeps your own history organized.

Because these injectables overlap heavily, comparing them sharpens your questions. Our notes on the carnitine-and-B12 blend Red Line and the high-volume DCA product BO-DCA show how similar formulas get positioned for different uses.

A grounded takeaway

Sedy Line is a 60 ml sodium deoxycholate lipolytic with L-carnitine, B12, and botanicals, positioned for face and body. The honest bottom line is regulatory: deoxycholic acid is FDA-approved only for under-chin fat as Kybella, body use is off-label, and the FDA warns non-approved fat-dissolving injections can be harmful. Route candidacy and the procedure to a licensed professional. The guide is attached for reference only.

Sources